{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:43:06Z","timestamp":1792546986512,"version":"4.5.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00111","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T04:21:12Z","timestamp":1582258872000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Efficacy of a Combined Treatment of Botulinum Toxin and Intensive Physiotherapy in Hereditary Spastic Paraplegia"],"prefix":"10.3389","volume":"14","author":[{"given":"Gabriella","family":"Paparella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinela","family":"Vavla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Martinuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4.","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"B2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified Ashworth scale of muscle spasticity.","volume":"67","author":"Bohannon","year":"1987","journal-title":"Phys. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.apmr.2014.10.006","article-title":"Two-minute walk test performance by adults 18 to 85 years: normative values, reliability, and responsiveness.","volume":"96","author":"Bohannon","year":"2015","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"B4","author":"Christensen","year":"2019","journal-title":"ordinal - Regression Models for Ordinal Data. R Package Version 2019.4-25."},{"key":"B5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2340\/16501977-1909","article-title":"Functional effects of botulinum toxin type-A treatment and subsequent stretching of spastic calf muscles: a study in patients with hereditary spastic paraplegia.","volume":"47","author":"de Niet","year":"2015","journal-title":"J. Rehabil. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12311-016-0803-z","article-title":"Hereditary spastic paraplegia: clinical and genetic hallmarks.","volume":"16","author":"de Souza","year":"2017","journal-title":"Cerebellum"},{"key":"B7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/jnnp.58.2.232","article-title":"Treatment of chronic limb spasticity with botulinum toxin A.","volume":"58","author":"Dunne","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","article-title":"Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.","volume":"126","author":"Fink","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1055\/s-0034-1386767","article-title":"Hereditary spastic paraplegia: clinical principles and genetic advances.","volume":"34","author":"Fink","year":"2014","journal-title":"Semin. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1177\/0883073809356037","article-title":"Botulinum toxin injections for pediatric patients with hereditary spastic paraparesis.","volume":"25","author":"Geva-Dayan","year":"2010","journal-title":"J. Child Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1055\/s-2008-1041143","article-title":"Hereditary spastic paraplegias.","volume":"13","author":"Harding","year":"1993","journal-title":"Semin. Neurol."},{"key":"B12","first-page":"98","article-title":"Experimental development of the graphic rating method.","volume":"18","author":"Hayes","year":"1921","journal-title":"Psychol. Bull."},{"key":"B13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/mds.21809","article-title":"Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia\u2014 Report of 19 cases.","volume":"23","author":"Hecht","year":"2008","journal-title":"Mov. Disord."},{"key":"B14","first-page":"204","article-title":"Botulin toxin for spasticity in spinal cord damage by treating the motor endplate.","volume":"138","author":"Keren","year":"2000","journal-title":"Harefuah"},{"key":"B15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.neurol.2015.02.017","article-title":"Clinical and genetic heterogeneity in hereditary spastic paraplegias: from SPG1 to SPG72 and still counting.","volume":"171","author":"Klebe","year":"2015","journal-title":"Rev. Neurol."},{"key":"B16","author":"Lenth","year":"2019","journal-title":"emmeans: Estimated Marginal Means, aka Least-Squares Means. R Package Version 1.3.5."},{"key":"B17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.expneurol.2014.06.011","article-title":"Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms.","volume":"261","author":"Lo Giudice","year":"2014","journal-title":"Exp. Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/jnnp.69.2.150","article-title":"Hereditary spastic paraparesis: a review of new developments.","volume":"69","author":"McDermott","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/WCO.0000000000000585","article-title":"Hereditary ataxias and paraparesias: clinical and genetic update.","volume":"31","author":"Parodi","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1191\/0269215506cr922oa","article-title":"The tardieu scale differentiates contracture from spasticity whereas the ashworth scale is confounded by It.","volume":"20","author":"Patrick","year":"2006","journal-title":"Clin. Rehabil."},{"key":"B21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1161\/01.str.26.6.982","article-title":"Classification of walking handicap in the stroke population.","volume":"26","author":"Perry","year":"1995","journal-title":"Stroke"},{"key":"B22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejpn.2010.07.009","article-title":"3D gait analysis in patients with hereditary spastic paraparesis and spastic diplegia: a kinematic, kinetic and EMG comparison.","volume":"15","author":"Piccinini","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons.","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J. Am. Geriatr. Soc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2174\/1381612822666151204001830","article-title":"Combined treatment Fkt-botulinum toxin type A (Btx-A) in patients with strumpell-lorrain disease.","volume":"22","author":"Riccardo","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/apmr.2001.9396","article-title":"Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment.","volume":"82","author":"Rossier","year":"2001","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"B26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1468-1331.2006.01617.x","article-title":"Botulinum toxin injection in patients with hereditary spastic paraparesis.","volume":"14","author":"Rousseaux","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","article-title":"The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.","volume":"42","author":"Ruano","year":"2014","journal-title":"Neuroepidemiology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1212\/01.wnl.0000228242.53336.90","article-title":"The spastic paraplegia rating scale (SPRS): a reliable and valid measure of disease severity.","volume":"67","author":"Sch\u00fcle","year":"2006","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1590\/0004-282x20180013","article-title":"Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations.","volume":"76","author":"Servelhere","year":"2018","journal-title":"Arq. Neuropsiquiatr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00702-007-0833-2","article-title":"Spasticity treatment with botulinum toxins.","volume":"115","author":"Ward","year":"2008","journal-title":"J. Neural Transm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: a review of three commonly used pain rating scales.","volume":"14","author":"Williamson","year":"2005","journal-title":"J. Clin. Nurs."},{"key":"B32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.1964.03070130073046","article-title":"WMA\u2019s declaration of helsinki serves as guide to physicians. JAMA","year":"1964"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00111\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T04:21:15Z","timestamp":1582258875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00111\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":32,"alternative-id":["10.3389\/fnins.2020.00111"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00111","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737530384.793582717","asserted-by":"object"}]},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]},"article-number":"111"}}